Related Experiment Video
Updated: Mar 14, 2026

Surgical Transplantation of Tumor Cells into the Spinal Cord of Mice
Published on: December 27, 2024
Spindle Cell Lipomas Arising at Atypical Locations.
Nasir Ud Din1, Pingchuan Zhang2, William R Sukov2
1From the Department of Pathology and Laboratory Medicine, Aga Khan University Hospital, Karachi, Pakistan.
Spindle cell lipomas (SCLs) can occur in unusual body areas, not just the typical neck and back. This study found SCLs in the trunk and extremities, with a balanced sex distribution in these non-classic cases.
Area of Science:
- Dermatopathology
- Surgical Pathology
- Oncology
Background:
- Spindle cell lipomas (SCLs) are typically found on the posterior neck, upper back, and shoulders.
- These benign lipomatous neoplasms predominantly affect older males.
Purpose of the Study:
- To investigate the occurrence of SCLs at non-classic anatomical sites.
- To characterize the clinical and pathological features of SCLs in atypical locations.
Main Methods:
- Retrospective review of archival cases of SCL.
- Analysis of tumor location, patient demographics, and immunohistochemical markers (CD34, desmin, Rb).
Main Results:
- 57 out of 439 SCL cases occurred at atypical sites (trunk, lower extremities, distal upper extremities).
- Atypical SCLs showed a near-equal sex distribution (32 males, 25 females).
- Immunohistochemistry revealed consistent CD34 positivity, frequent loss of Rb expression, and absence of CPM/MDM2 amplification.
Conclusions:
- Spindle cell lipomas can manifest in the trunk, lower extremities, and distal upper extremities.
- Unlike classic SCLs, those in atypical sites have a balanced sex distribution.
- Awareness of SCLs at non-classic sites is crucial for accurate diagnosis and to prevent misclassification.
More Related Videos
07:36Isolation of Human Lymphatic Endothelial Cells by Multi-parameter Fluorescence-activated Cell Sorting
Published on: May 1, 2015
08:57Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors
Published on: May 17, 2024